Showing results (651-660 of 929) with videos related to

Sort By:
Pageof 93
Implementation Science : IS|October 26, 2011
Evaluating the effectiveness of a tailored multifaceted performance feedback intervention to improve the quality of care: protocol for a cluster randomized trial in intensive careSabine N van der Veer, Maartje L G de Vos, Kitty J Jager, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 17, 2020
Kidney function and symptom development over time in elderly patients with advanced chronic kidney disease: results of the EQUAL cohort studyCynthia J Janmaat, Merel van Diepen, Yvette Meuleman, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|August 13, 2003
Prognostic value of S-100-beta serum concentration in patients with uveal melanomaGuy S O A Missotten, Nancy E M L Tang, Catharina M Korse, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|December 9, 2010
Travel time from home to hospital and adverse perinatal outcomes in women at term in the NetherlandsA C J Ravelli, K J Jager, M H de Groot, et al.
Plos One|March 13, 2015
Digital PCR validates 8q dosage as prognostic tool in uveal melanomaMieke Versluis, Mark J de Lange, Sake I van Pelt, et al.
Cancers|July 21, 2019
Ischemia Is Related to Tumour Genetics in Uveal MelanomaNiels J Brouwer, Annemijn P A Wierenga, Gülçin Gezgin, et al.
Ophthalmology|September 8, 2024
Survival in Patients with Uveal Melanoma Is Linked to Genetic Variation at HERC2 Single Nucleotide Polymorphism rs12913832Maria Chiara Gelmi, Laurien E Houtzagers, Annemijn P A Wierenga, et al.
Experimental Eye Research|January 6, 2021
In-vivo imaging for assessing tumor growth in mouse models of ocular melanomaOrtal Zaks, Dimitri Gaber, Keren Ben-Yaakov, et al.
Cancers|December 15, 2020
HDAC Inhibition Increases HLA Class I Expression in Uveal MelanomaZahra Souri, Aart G Jochemsen, Mieke Versluis, et al.
International Journal of Radiation Oncology, Biology, Physics|October 19, 1999
The influence of the boost in breast-conserving therapy on cosmetic outcome in the EORTC "boost versus no boost" trial. EORTC Radiotherapy and Breast Cancer Cooperative Groups. European Organization for Research and Treatment of CancerC Vrieling, L Collette, A Fourquet, et al.
Pageof 93